131 related articles for article (PubMed ID: 22660802)
1. Prediction of cardiovascular events in patients with ankylosing spondylitis and psoriatic arthritis: role of lipoproteins in a high-risk population.
Semb AG; Kvien TK; DeMicco DA; Fayyad R; Wun CC; LaRosa J; Betteridge J; Pedersen TR; Holme I
J Rheumatol; 2012 Jul; 39(7):1433-40. PubMed ID: 22660802
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.
Tam LS; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Li TK; Yu T; Zhu YE; Wong KC; Kun EW; Li EK
Rheumatology (Oxford); 2008 May; 47(5):718-23. PubMed ID: 18400833
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis.
Mok CC; Ko GT; Ho LY; Yu KL; Chan PT; To CH
Arthritis Care Res (Hoboken); 2011 Feb; 63(2):195-202. PubMed ID: 20890981
[TBL] [Abstract][Full Text] [Related]
4. Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction.
Mahajan N; Ference BA; Arora N; Madhavan R; Bhattacharya P; Sudhakar R; Sagar A; Wang Y; Sacks F; Afonso L
Am J Cardiol; 2012 Jun; 109(12):1694-9. PubMed ID: 22465317
[TBL] [Abstract][Full Text] [Related]
5. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.
Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
Arthritis Res Ther; 2017 May; 19(1):102. PubMed ID: 28521824
[TBL] [Abstract][Full Text] [Related]
6. Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic.
Rollefstad S; Kvien TK; Holme I; Eirheim AS; Pedersen TR; Semb AG
Ann Rheum Dis; 2013 Dec; 72(12):1968-74. PubMed ID: 23264359
[TBL] [Abstract][Full Text] [Related]
7. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
[TBL] [Abstract][Full Text] [Related]
8. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
Langsted A; Freiberg JJ; Nordestgaard BG
Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk profile in patients with spondyloarthritis.
Papagoras C; Markatseli TE; Saougou I; Alamanos Y; Zikou AK; Voulgari PV; Kiortsis DN; Drosos AA
Joint Bone Spine; 2014 Jan; 81(1):57-63. PubMed ID: 23731637
[TBL] [Abstract][Full Text] [Related]
10. Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.
Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shishido K; Takahashi K; Hosaka N; Ikeda M; Sanada D; Shibata T
PLoS One; 2017; 12(5):e0177980. PubMed ID: 28542510
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.
Peters MJ; van der Horst-Bruinsma IE; Dijkmans BA; Nurmohamed MT
Semin Arthritis Rheum; 2004 Dec; 34(3):585-92. PubMed ID: 15609262
[TBL] [Abstract][Full Text] [Related]
12. Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis.
Papagoras C; Voulgari PV; Drosos AA
Clin Exp Rheumatol; 2013; 31(4):612-20. PubMed ID: 23406817
[TBL] [Abstract][Full Text] [Related]
13. Plasma lipoprotein levels as predictors of cardiovascular death in women.
Bass KM; Newschaffer CJ; Klag MJ; Bush TL
Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
[TBL] [Abstract][Full Text] [Related]
14. Progeny's lipid and lipoprotein levels by parental mortality. The Lipid Research Clinics Program Prevalence Study.
Glueck CJ; Laskarzewski PM; Suchindran CM; Chambless LE; Barrett-Connor E; Stewart P; Heiss G; Tyroler HA
Circulation; 1986 Jan; 73(1 Pt 2):I51-61. PubMed ID: 3940684
[TBL] [Abstract][Full Text] [Related]
15. Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events.
Laitinen DL; Manthena S
Adv Ther; 2010 Apr; 27(4):233-44. PubMed ID: 20437214
[TBL] [Abstract][Full Text] [Related]
16. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.
Petersson U; Ostgren CJ; Brudin L; Nilsson PM
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.
Nissen CB; Hørslev-Petersen K; Primdahl J
Rheumatol Int; 2017 Jan; 37(1):113-120. PubMed ID: 27889826
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study.
de Vries MK; Arkema EV; Jonsson J; Bruchfeld J; Jacobsson LTH; Askling J;
Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1563-1567. PubMed ID: 29195024
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.
Edson-Heredia E; Zhu B; Lefevre C; Wang M; Barrett A; Bushe CJ; Cox A; Wu JJ; Maeda-Chubachi T
J Eur Acad Dermatol Venereol; 2015 May; 29(5):955-63. PubMed ID: 25352213
[TBL] [Abstract][Full Text] [Related]
20. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
